DTC-0208

N/A

Report date: 2024/09/26 18:01:05
NME

Base Information

Drug NameDTC-0208
Drug Alias NameDTC-0208
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 4 inhibitors
TargetsPolo like kinase 4
Therapy Area/IndicationsColorectal NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDELiver Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDELiver Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A